Private Lending Software with Open-Ended API; Lightning Docs 2.0 Released

Lightning Docs™, the Official Loan Documents of the American Association of Private Lenders®,announces the launch of its Lightning Docs 2.0 platform. This comprehensive development project, which took over a year to complete, empowers clients with successful API connections to enhance and expedite their processes. https://mma.prnewswire.com/media/2535215/Geraci_Lightning_Docs.jpg We service more than 60% of the top 50 largest

LISA Launches First Diagnostics Crowdfund Projects in Response to FDA Final LDT Rule

Goal to Bring CAP/COLA Labs Together for Innovative FDA-Compliant Assays TheLaboratory Integration Strategic Association(LISA) proudly announces the first crowdfund projects that empower labs to navigate the evolving FDA regulatory landscape for Laboratory Developed Tests (LDTs), focusing on urinary tract infection (UTI) assays. These UTI projects mark a new era where accredited clinical labs cooperate with

PCB Encapsulation Market worth $5.59 billion by 2029 – Exclusive Report by MarketsandMarkets™

The report”PCB Encapsulation Marketby Resin Type (Epoxy, Acrylic), Curing Type (UV-Cure, Heat Cure, Room Temperature Cure), Application (Consumer Electronics, Automotive Electronics, Medical Devices), Product Type – Global Forecast to 2029″, is projected to reach USD 5.59 billion by 2029, at a CAGR of 8.8% from USD 3.67 billion in 2024. Some of the major forces

Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED)

Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive topline results from its Phase Ib/II clinical trial of MHB018A in patients with active TED. MHB018A is a novel subcutaneous VHH-Fc fusion protein that targets the insulin-like growth factor-1 receptor (IGF-1R), a validated mechanism of action

HUYA Inc. to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Earnings Webinar Scheduled for 7:00 a.m. ET on November 12, 2024- HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game live streaming platform in China, today announced that it will report its third quarter 2024 unaudited financial results on Tuesday, November 12, 2024, before the open of U.S. markets. The Company’smanagement will host

PEOPLES BANCORP INC. ANNOUNCES THIRD QUARTER 2024 RESULTS

Peoples Bancorp Inc. (“Peoples”) (NASDAQ: PEBO) today announced results for the quarter ended September 30, 2024. Net income totaled $31.7 million for the third quarter of 2024, representing earnings per diluted common share of $0.89. In comparison, Peoples reported net income of $29.0 million, representing earnings per diluted common share of $0.82, for the second

Dignify Therapeutics Selected as a Praxis SCI Accelerate Company

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program ‘geared towards healthcare companies with a product ready to launch into market that will transform the lives of people living

Polaris Inc. Third Quarter 2024 Financial Results Available on Company’s Website

Polaris Inc. (NYSE: PII) reported third quarter 2024 financial results today through an earnings release posted on the Company’s Investor Relations website atir.polaris.com. The earnings release will be furnished with the Securities and Exchange Commission on a Form 8-K and is available at sec.gov. The Company will also hold a conference call with analysts and

Modine Selected as Thermal Solutions Supplier for GILLIG Hybrid-Electric Bus Platform

Modine EVantage™ Thermal Management Systems, optimize battery and power electronics thermal performance, increasing system efficiency of hybrid bus As the transportation industry powers towards zero-emissions solutions, Modine(NYSE: MOD), a diversified global leader in thermal management technology, today announced it is the thermal management supplier for GILLIG, a leading manufacturer of heavy-duty transit buses in the

Scroll to Top